These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 29364965)

  • 1. Correction: Comparison of the Predicted Population Coverage of Tuberculosis Vaccine Candidates Ag85B-ESAT-6, Ag85B-TB10.4, and Mtb72f via a Bioinformatics Approach.
    Davila J; McNamara LA; Yang Z
    PLoS One; 2012; 7(10):. PubMed ID: 29364965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the predicted population coverage of tuberculosis vaccine candidates Ag85B-ESAT-6, Ag85B-TB10.4, and Mtb72f via a bioinformatics approach.
    Davila J; McNamara LA; Yang Z
    PLoS One; 2012; 7(7):e40882. PubMed ID: 22815851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chimaeric protein improved immunogenicity compared with fusion protein of Ag85B and ESAT-6 antigens of Mycobacterium tuberculosis.
    Xu Y; Wang B; Chen J; Wang Q; Zhu B; Shen H; Qie Y; Wang J; Wang H
    Scand J Immunol; 2006 Nov; 64(5):476-81. PubMed ID: 17032239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection of macaques against Mycobacterium tuberculosis infection by a subunit vaccine based on a fusion protein of antigen 85B and ESAT-6.
    Langermans JA; Doherty TM; Vervenne RA; van der Laan T; Lyashchenko K; Greenwald R; Agger EM; Aagaard C; Weiler H; van Soolingen D; Dalemans W; Thomas AW; Andersen P
    Vaccine; 2005 Apr; 23(21):2740-50. PubMed ID: 15780721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alteration of epitope recognition pattern in Ag85B and ESAT-6 has a profound influence on vaccine-induced protection against Mycobacterium tuberculosis.
    Bennekov T; Dietrich J; Rosenkrands I; Stryhn A; Doherty TM; Andersen P
    Eur J Immunol; 2006 Dec; 36(12):3346-55. PubMed ID: 17109467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of various antigen compounds of tuberculosis composite antigen vaccine on the immune function in mice].
    Wang P; Xu M; Chen BW; DU WX; Yang L; Jing SR; Wang GZ
    Zhonghua Jie He He Hu Xi Za Zhi; 2011 Apr; 34(4):269-73. PubMed ID: 21609610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The candidate tuberculosis vaccine Mtb72F/AS02 in PPD positive adults: a randomized controlled phase I/II study.
    Spertini F; Audran R; Lurati F; Ofori-Anyinam O; Zysset F; Vandepapelière P; Moris P; Demoitié MA; Mettens P; Vinals C; Vastiau I; Jongert E; Cohen J; Ballou WR
    Tuberculosis (Edinb); 2013 Mar; 93(2):179-88. PubMed ID: 23219236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ag85B-ESAT-6 adjuvanted with IC31® promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in volunteers with previous BCG vaccination or tuberculosis infection.
    van Dissel JT; Soonawala D; Joosten SA; Prins C; Arend SM; Bang P; Tingskov PN; Lingnau K; Nouta J; Hoff ST; Rosenkrands I; Kromann I; Ottenhoff TH; Doherty TM; Andersen P
    Vaccine; 2011 Mar; 29(11):2100-9. PubMed ID: 21256189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequence conservation analysis and in silico human leukocyte antigen-peptide binding predictions for the Mtb72F and M72 tuberculosis candidate vaccine antigens.
    Mortier MC; Jongert E; Mettens P; Ruelle JL
    BMC Immunol; 2015 Oct; 16():63. PubMed ID: 26493839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective immunity to tuberculosis with Ag85B-ESAT-6 in a synthetic cationic adjuvant system IC31.
    Agger EM; Rosenkrands I; Olsen AW; Hatch G; Williams A; Kritsch C; Lingnau K; von Gabain A; Andersen CS; Korsholm KS; Andersen P
    Vaccine; 2006 Jun; 24(26):5452-60. PubMed ID: 16675077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant Ag85B vaccine by taking advantage of characteristics of human parainfluenza type 2 virus vector showed Mycobacteria-specific immune responses by intranasal immunization.
    Watanabe K; Matsubara A; Kawano M; Mizuno S; Okamura T; Tsujimura Y; Inada H; Nosaka T; Matsuo K; Yasutomi Y
    Vaccine; 2014 Mar; 32(15):1727-35. PubMed ID: 24486310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Ag85B protein of the BCG vaccine facilitates macrophage uptake but is dispensable for protection against aerosol Mycobacterium tuberculosis infection.
    Prendergast KA; Counoupas C; Leotta L; Eto C; Bitter W; Winter N; Triccas JA
    Vaccine; 2016 May; 34(23):2608-15. PubMed ID: 27060378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A study of the protective effect of the DNA vaccine encoding tubercle antigen 85B with MPT64 in mice challenged with Mycobacterium tuberculosis].
    Luo XD; Zhu DY; Chen Q; Jiang Y; Jiang S; Yang C
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Sep; 27(9):611-6. PubMed ID: 15498274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The development and preliminary evaluation of a new Mycobacterium tuberculosis vaccine comprising Ag85b, HspX and CFP-10:ESAT-6 fusion protein with CpG DNA and aluminum hydroxide adjuvants.
    Chen L; Xu M; Wang ZY; Chen BW; Du WX; Su C; Shen XB; Zhao AH; Dong N; Wang YJ; Wang GZ
    FEMS Immunol Med Microbiol; 2010 Jun; 59(1):42-52. PubMed ID: 20298499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adult-like anti-mycobacterial T cell and in vivo dendritic cell responses following neonatal immunization with Ag85B-ESAT-6 in the IC31 adjuvant.
    Kamath AT; Rochat AF; Valenti MP; Agger EM; Lingnau K; Andersen P; Lambert PH; Siegrist CA
    PLoS One; 2008; 3(11):e3683. PubMed ID: 18997860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity and protective efficacy of a fusion protein vaccine consisting of antigen Ag85B and HspX against Mycobacterium tuberculosis infection in mice.
    Li Q; Yu H; Zhang Y; Wang B; Jiang W; Da Z; Xian Q; Wang Y; Liu X; Zhu B
    Scand J Immunol; 2011 Jun; 73(6):568-76. PubMed ID: 21323695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection against tuberculosis induced by oral prime with Mycobacterium bovis BCG and intranasal subunit boost based on the vaccine candidate Ag85B-ESAT-6 does not correlate with circulating IFN-gamma producing T-cells.
    Badell E; Nicolle F; Clark S; Majlessi L; Boudou F; Martino A; Castello-Branco L; Leclerc C; Lewis DJ; Marsh PD; Gicquel B; Winter N
    Vaccine; 2009 Jan; 27(1):28-37. PubMed ID: 18977269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel DNA vaccine for protective immunity against virulent Mycobacterium bovis in mice.
    Liu S; Gong Q; Wang C; Liu H; Wang Y; Guo S; Wang W; Liu J; Shao M; Chi L; Zhao K; Wang Z; Shi Y; Huang Y; Guli A; Zhang C; Kong X
    Immunol Lett; 2008 May; 117(2):136-45. PubMed ID: 18339431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Constructing shuttle plasmid fusion expressing Ag85B-ESAT-6 on the surface of Mycobacterium].
    Shi CH; Fan XL; Shi JR; Xu ZK; Li Y; Bai YN; Xun Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Apr; 27(4):249-52. PubMed ID: 15144616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel recombinant BCG coexpressing Ag85B, ESAT-6 and Rv2608 elicits significantly enhanced cellular immune and antibody responses in C57BL/6 mice.
    Lu Y; Xu Y; Yang E; Wang C; Wang H; Shen H
    Scand J Immunol; 2012 Sep; 76(3):271-7. PubMed ID: 22671973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.